Goodwin advised Life Edit Therapeutics on the deal. Novo Nordisk and Life Edit Therapeutics, Inc., an ElevateBio company, announced a research and development collaboration to discover and...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Debevoise & Plimpton advised Carlyle on the deal, while Cooley and Gilbert+Tobin advised Opthea. Global investment firm Carlyle and its life sciences franchise...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised CathWorks on the deal. CathWorks announced its acquisition option agreement and co-promotion agreement with Medtronic (NYSE: MDT). Under the acquisition option agreement, Medtronic will...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Ionpath, Inc. on the deal. Thermo Fisher Scientific announced its strategic investment in Ionpath, Inc. Ionpath, Inc., based in Menlo Park, California, is a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the underwriters in the IPO while Goodwin advised PepGen. PepGen, Inc., a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with...
You must be a Standard 1 Year member to access this content.
Goodwin advised Blackstone Life Sciences on the deal. Blackstone Life Sciences announced its strategic, risk-sharing financing collaboration with Sanofi, in which Blackstone will provide Sanofi with up...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Lyra Therapeutics, Inc. on the deal. Lyra Therapeutics, Inc. (Nasdaq: LYRA) announced its strategic partnership and exclusive license agreement with LianBio for the...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Coridea on the deal. Coridea announced its collaboration with Deerfield Management Company, named Deerfield Device Design and Development Catalyst, to advance medtech innovation...
You must be a Standard 1 Year member to access this content.
